Progeroid Syndrome Patients with ZMPSTE24 Deficiency Could Benefit When Treated with Rapamycin and Dimethylsulfoxide
Barış Akıncı1, Shireesha Sankella2, Christopher Gilpin3, Keeichi Ozono4, Abhimanyu Garg5, Anıl K. Agarwal51Dokuz Eylül University Faculty Of Medicine, Division Of Endocrinology, Izmir, Turkey 2University Of Texas Southwestern Medical Center, Division Of Nutrition And Metabolic Diseases, Center For Human Nutrition, Department Of Internal Medicine, Texas, Usa 3University Of Texas Southwestern Medical Center, Molecular And Cellular Imaging, Department Of Cell Biology, Texas, Usa 4Osaka University Graduate School Of Medicine, Department Of Pediatrics, Osaka, Japan 5University Of Texas Southwestern Medical Center, Center For Human Nutrition, Department Of Internal Medicine, Division Of Nutrition And Metabolic Diseases, Texas, Usa
Barış Akıncı, Shireesha Sankella, Christopher Gilpin, Keeichi Ozono, Abhimanyu Garg, Anıl K. Agarwal. Progeroid Syndrome Patients with ZMPSTE24 Deficiency Could Benefit When Treated with Rapamycin and Dimethylsulfoxide. J Clin Res Pediatr Endocrinol. 2017; 9(1): 31-31 Manuscript Language: English